Products
Platform
Research
Market
Learn
Partner
Support
IPO

V

Venmax Drugs & Pharmaceuticals Share Price

25.74
+1.14 (4.63%)
VENMAX • 02 Jan, 2026 | 03:29 PM

10Y Annualised Return

23.97%

The current prices are delayed, login or Open Demat Account for live prices.

Venmax Drugs & Pharmaceuticals Stock Performance

1W Return-5.71
1Y Return33.30
Today's Low23.37
Prev. Close24.60
Mkt Cap (Cr.)20.61
1M Return-14.49
3Y Return515.79
52-Week High36.96
Open24.60
PE Ratio59.86
6M Return1.54
Today's High25.83
52-Week Low17.51
Face Value10

Venmax Drugs & Pharmaceuticals Company background

Founded in: 1988
Venmax Drugs Pharmaceuticals Limited, (VDPL) was initially incorporated as Private Company as Yenkay Medico Private Limited, on 28 September, 1998. The Company thereafter changed its name to Yenkey Drugs Pharmaceuticals Private Limited on 18 January, 1995. It became a Public Limited Company on February 3, 1995 as Yenkey Drugs Pharmaceuticals Limited. Finally, the Company changed its name to Venmax Drugs Pharmaceuticals Limited on April 13, 2009. For the past six months, Company focused on establishing chain of Medical Stores with a brand name as Ananya Pharma under the Venmax Drugs Pharma Limited, with the backing support of Formulations plant (Suzichem Labs). At present, Company is engaged in the business of pharmaceutical products, drug intermediaries APIs etc. The Company is developing the oncology products in RD. Planning to establish a manufacturing UNIT with cGMP facility at Pharma Cluster at Hyderabad, to meet the export demand.

Venmax Drugs & Pharmaceuticals Share Price Today


As of 5 Jan 2026, Venmax Drugs & Pharmaceuticals share price is ₹25.7. The stock opened at ₹24.6 and had closed at ₹24.6 the previous day. During today’s trading session, Venmax Drugs & Pharmaceuticals share price moved between ₹23.37 and ₹25.83, with an average price for the day of ₹24.60. Over the last 52 weeks, the stock has recorded a low of ₹17.51 and a high of ₹36.96. In terms of performance, Venmax Drugs & Pharmaceuticals share price has increased by 3.6% over the past six months and has increased by 27.40% over the last year.
Read More
View details of Market Depth

Venmax Drugs & Pharmaceuticals Fundamental

Market Cap (in crs)

20.61

Face Value

10

Turnover (in lacs)

0.44

Key Metrics

Qtr Change %
30.36% Fall from 52W High
27.7
Dividend yield 1yr %
0

Venmax Drugs & Pharmaceuticals Shareholding Pattern

Promoter
23.1%
Public
76.9%

Venmax Drugs & Pharmaceuticals Technical Analysis

Moving Averages Analysis
25.74
Current Price
Bullish Moving Averages
3
Bearish Moving Averages
13
Day EMA5
25.50
Day EMA10
26.10
Day EMA12
26.30
Day EMA20
26.80
Day EMA26
27.00
Day EMA50
27.20
Day EMA100
26.80
Day EMA200
24.90
Delivery & Volume
Loading chart...

Day

100.00%

Week

100.00%

Month

100.00%

Delivery & Volume

24.98
Pivot
Resistance
First Resistance
26.59
Second Resistance
27.44
Third Resistance
29.05
Support
First Support
24.13
Second support
22.52
Third Support
21.67
Relative Strength Index
42.63
Money Flow Index
47.86
MACD
-0.70
MACD Signal
-0.40
Average True Range
2.11
Average Directional Index
17.44
Rate of Change (21)
-12
Rate of Change (125)
2.80
Compare

Venmax Drugs & Pharmaceuticals Latest News

26 DEC 2025 | Friday
25 NOV 2025 | Tuesday
24 NOV 2025 | Monday

Please be aware that Venmax Drugs & Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account